Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The effect of a proton pump inhibitor on gastrointestinal (GI) microbiota was evaluated. Eight healthy 9-month-old dogs (four males and four females) received omeprazole (1.1 mg kg(-1) ) orally twice a day for 15 days. Fecal samples and endoscopic biopsies from the stomach and duodenum were obtained on days 30 and 15 before omeprazole administration, on day 15 (last day of administration), and 15 days after administration. The microbiota was evaluated using 16S rRNA gene 454-pyrosequencing, fluorescence in situ hybridization, and qPCR. In the stomach, pyrosequencing revealed a decrease in Helicobacter spp. during omeprazole (median 92% of sequences during administration compared to > 98% before and after administration; P = 0.0336), which was accompanied by higher proportions of Firmicutes and Fusobacteria. FISH confirmed this decrease in gastric Helicobacter (P < 0.0001) and showed an increase in total bacteria in the duodenum (P = 0.0033) during omeprazole. However, Unifrac analysis showed that omeprazole administration did not significantly alter the overall phylogenetic composition of the gastric and duodenal microbiota. In feces, qPCR showed an increase in Lactobacillus spp. during omeprazole (P < 0.0001), which was accompanied by a lower abundance of Faecalibacterium spp. and Bacteroides-Prevotella-Porphyromonas in the male dogs. This study suggests that omeprazole administration leads to quantitative changes in GI microbiota of healthy dogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“The decrease in Faecalibacterium during omeprazole administration in the male dogs is especially interesting, as these bacteria possess anti-inflammatory properties (Sokol et al., 2008) and have been found to be depleted during episodes of colitis in humans (Sokol et al.”
BackgroundLow counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275 · cited 1×
“, 2008) and have been found to be depleted during episodes of colitis in humans (Sokol et al., 2009).”
BackgroundSystematic review of the risk of enteric infection in patients taking acid suppression
Leonard, J., Marshall, J. K., & Moayyedi, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01275.x · Cited by 633 · cited 1×
“, 2008) and a higher risk of enteric infections (Leonard et al., 2007), respectively.”
BackgroundDiversity of the human gastrointestinal tract microbiota revisited
Rajilić‐Stojanović, M., Smidt, H., & De Vos, W. M. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01369.x · Cited by 559 · cited 1×
“However, culture techniques are by definition restricted to cultivable microorganisms, a group representing a small proportion of all GI microbiota (Rajilic-Stojanovic et al., 2007).”
BackgroundIdentification of Human Liver Cytochrome P450 Isoforms Mediating Omeprazole Metabolism
ANDERSSON, T., MINERS, J. O., VERONESE, M. E., TASSANEEYAKUL, W., TASSANEEYAKUL, W., MEYER, U. A., & BIRKETT, D. J. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb00410.x · Cited by 230
Cited by
The Gastrointestinal Microbiome: A Review
Barko, P. C., McMichael, M. A., Swanson, K. S., & Williams, D. A. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14875 · Cited by 750
The Fecal Microbiome in Dogs with Acute Diarrhea and Idiopathic Inflammatory Bowel Disease
Suchodolski, J. S., Markel, M. E., Garcia-Mazcorro, J. F., Unterer, S., Heilmann, R. M., Dowd, S. E., Kachroo, P., Ivanov, I., Minamoto, Y., Dillman, E. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051907 · Cited by 459
Self-citationMinamoto, Y., Otoni, C. C., Steelman, S. M., Büyükleblebici, O., Steiner, J. M., Jergens, A. E., & Suchodolski, J. S. (2015) · Gut Microbes · doi:10.1080/19490976.2014.997612 · Cited by 340
Self-citationMicrobiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs
Honneffer, J. B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16489 · Cited by 279
Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications
Le Bastard, Q., Al‐Ghalith, G. A., Grégoire, M., Chapelet, G., Javaudin, F., Dailly, E., Batard, E., Knights, D., & Montassier, E. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14451 · Cited by 263
“Kanno et al and Garcia-Mazcorro et al also suggest that the increase in the bacterial load entering the large intestine may be partly responsible for the faecal microbiome alterations associated with PPI medication.(99,100) Another contribution to faecal microbiome alterations associated with inhibition of gastric aci…”
Rossi, G., Pengo, G., Caldin, M., Palumbo Piccionello, A., Steiner, J. M., Cohen, N. D., Jergens, A. E., & Suchodolski, J. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094699 · Cited by 255
Self-citationThe Skin Microbiome in Healthy and Allergic Dogs
Rodrigues Hoffmann, A., Patterson, A. P., Diesel, A., Lawhon, S. D., Ly, H. J., Stephenson, C. E., Mansell, J., Steiner, J. M., Dowd, S. E., Olivry, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083197 · Cited by 255
Self-citationSchmidt, M., Unterer, S., Suchodolski, J. S., Honneffer, J. B., Guard, B. C., Lidbury, J. A., Steiner, J. M., Fritz, J., & Kölle, P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0201279 · Cited by 206
Self-citationThe Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome
Freedberg, D. E., Lebwohl, B., & Abrams, J. A. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.08.008 · Cited by 195
Diagnosis and interpretation of intestinal dysbiosis in dogs and cats
Suchodolski, J. S. (2016) · The Veterinary Journal · doi:10.1016/j.tvjl.2016.04.011 · Cited by 179
Self-citationSeto, C. T., Jeraldo, P., Orenstein, R., Chia, N., & DiBaise, J. K. (2014) · Microbiome · doi:10.1186/2049-2618-2-42 · Cited by 163
“and Bacteroides-Prevotella-Porphyromonas in the male dogs only [30].”
BackgroundInfluence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
Tsuda, A., Suda, W., Morita, H., Takanashi, K., Takagi, A., Koga, Y., & Hattori, M. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.20 · Cited by 164
“The reduced abundance of Faecalibacterium was also reported in the feces of dogs administered PPI for 15 days.(22) Faecalibacterium is known to possess anti-inflammatory properties and is depleted during episodes of inflammatory bowel diseases.”
BackgroundTakagi, T., Naito, Y., Inoue, R., Kashiwagi, S., Uchiyama, K., Mizushima, K., Tsuchiya, S., Okayama, T., Dohi, O., Yoshida, N., et al. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-78 · Cited by 121
“Garcia-Mazcorro et al. (19) demonstrated that omeprazole decreased Faecalibacterium in healthy male dogs.”
The effects of feeding and withholding food on the canine small intestinal microbiota
Kasiraj, A. C., Harmoinen, J., Isaiah, A., Westermarck, E., Steiner, J. M., Spillmann, T., & Suchodolski, J. S. (2016) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiw085 · Cited by 36
Self-citation(2023) · doi:10.1158/2159-8290.22541432.v1
Metadata
- Authors
- Garcia-Mazcorro, J. F., Suchodolski, J. S., Jones, K. R., Clark-Price, S. C., Dowd, S. E., Minamoto, Y., Markel, M., Steiner, J. M., & Dossin, O.
- Venue
- FEMS Microbiology Ecology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-12
- Volume
- 80
- Issue
- 3
- Pages
- 624-636
- ISSN
- 0168-6496 (ISSN-L)
- OpenAlex
- W2038810609
- Cited by
- 149
- References
- 5
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.